Related Experiment Video

Updated: Oct 1, 2025

Determining Bile Duct Density in the Mouse Liver
07:35

Determining Bile Duct Density in the Mouse Liver

Published on: April 30, 2019

7.0K

Multidisciplinary Management of Alagille Syndrome

Jagadeesh Menon1, Naresh Shanmugam1, Mukul Vij2

  • 1Department of Pediatric Gastroenterology & Hepatology, Dr Rela Institute & Medical Centre, Bharath Institute of Higher Education and Research, Chennai, India.

Journal of Multidisciplinary Healthcare
|March 3, 2022
PubMed

Insights

Alagille syndrome (ALGS) is a genetic disorder affecting multiple organs, often presenting in infancy with liver or heart issues. This review offers updated insights into managing its complex, multi-systemic challenges.

Area of Science:

  • Genetics and rare diseases
  • Hepatology
  • Pediatrics and adult medicine

Background:

  • Alagille syndrome (ALGS) is an autosomal dominant disorder impacting liver, skeleton, heart, kidneys, eyes, and major blood vessels.
  • Presentations vary widely across age groups, often suspected in infants with cholestasis or congenital heart disease.
  • Adult manifestations include vascular events like stroke and ruptured berry aneurysms.

Purpose of the Study:

  • To provide updated insights into the management of multi-systemic Alagille syndrome.
  • To address the need for a multidisciplinary approach due to the protean manifestations of ALGS.
  • To highlight unanswered questions in ALGS presentation and management.

Main Methods:

  • This is a review article.
  • Synthesizing current knowledge on Alagille syndrome management.
  • Compiling information on diagnosis, organ-specific involvement, and treatment strategies.

Main Results:

  • Liver transplantation is indicated for progressive cholestasis, decompensated cirrhosis, intractable pruritus, fractures, hepatocellular carcinoma, and xanthomas.
  • Optimized, renal-sparing immunosuppression is crucial post-transplant due to renal impairment risks.
  • A multidisciplinary team approach is essential for comprehensive patient care.

Conclusions:

  • Alagille syndrome requires a comprehensive, multidisciplinary management strategy.
  • Ongoing research is needed to further elucidate ALGS presentation and optimize treatment.
  • Early recognition and tailored interventions are key to improving outcomes for patients with ALGS.

Keywords:
Alagille syndromechronic cholestasiscongenital heart diseaseliver transplantationmultidisciplinary managementvascular anomalies

More Related Videos

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations14:58

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations

Published on: October 20, 2017

9.9K

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
133
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
154
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
555
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
164
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
62
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
232